Ultrasound Guided Peripheral Intravenous Catheterization in the Pediatric Intensive Care Unit.

March 12, 2020 updated by: Rabin Medical Center

Ultrasound Guided Peripheral Intravenous Catheterization in Children Hospitalized in the Pediatric Intensive Care Unit: a Randomized Controlled Prospective Trial.

This is a randomized controlled prospective study. The purpose of this study is to compare a recently described technique of ultrasound (US) guided, dynamic needle tip positioning (DNTP), to the traditional technique of vein visualization and palpation for peripheral venous cannulation in intubated, sedated, and mechanically ventilated pediatric intensive care unit (PICU) patients. First attempt success rate, overall success rate within 3 attempts or 10 minutes (whichever comes first), number of attempts to success, time to success and cannula sizes will be compared between the 2 techniques. The study will include intubated, sedated and mechanically ventilated children, aged 0-18 years, hospitalized in the PICU who require peripheral intravenous (PIV) access for their management.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Invasively ventilated
  2. Younger than 18 years
  3. Peripheral venous access required
  4. Difficult intravenous access (DIVA) score of 4 or greater (on a scale of 0-10 with higher scores implying more difficult access)

Exclusion Criteria:

  1. Refusal to consent
  2. Research staff not available

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Ultrasound Guided Dynamic Needle Tip Positioning Technique
In this arm the US transducer, protected with a sterile cover and sterile gel will be placed in the short axis above the distal end of the selected vein, moving the probe to place the vein in the center of the ultrasound screen under the middle mark of the image. The catheter needle will be inserted close to the transducer. The needle tip will be visualized as a white dot on the ultrasound screen. Then, the transducer will be shifted slightly proximally until the white dot disappears from the screen. The needle and the transducer will be moved alternately toward the patient several times to visualize the needle tip in real time. After penetrating the anterior wall of the vein, these steps will be repeated a few more times with a smaller insertion angle to visualize the white dot in the vein. Finally, the outer catheter will be fully advanced and the needle core will be extracted.
Catheterizations will be performed by one of three pediatric intensivists with vast experience in both traditional and US guided DNTP techniques for peripheral intravenous access. The operator will be allowed to independently choose which peripheral vein to cannulate. If necessary, patients will be given supplemental dose of sedation and analgesia in addition to the already given continuous infusions for invasive mechanical ventilation. Before puncture, the limb will be taped and maintained in an optimal position. A tourniquet will be placed proximal to the planned cannulation site. The site of puncture will be disinfected with Chlorhexidine gluconate 0.5% w/v, Alcohol 70% v/v. The choice of catheter will be left to the discretion of the operator. Available PIV cannulas include : 14 GA, 2X45 mm; 17 GA, 1.4X45 mm; 18 GA 1.2X45 mm; 20 GA 1X32mm BD Venflon™ and 24 GA, 0.7X19 mm; 26 GA 0.6X19 mm BD Neoflon™ (Becton Dickinson Infusion Therapy AB, Helsingborg, Sweden).
ACTIVE_COMPARATOR: Traditional insertion group
For traditional insertion technique insertion attempt will be blind or tactile. Otherwise, the same protocol and measurements as elaborated for the US guided group will be applied.
For traditional insertion technique insertion attempt will be blind or tactile.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of peripheral IV cannulation on first attempt
Time Frame: 10 minutes
Assessment of peripheral IV cannulation success on first attempt (Yes vs No)
10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall peripheral IV cannulation success rate
Time Frame: 10 minutes
The overall success rate of peripheral intravenous cannulation within 3 attempts.
10 minutes
Time to successful peripheral IV cannulation
Time Frame: up to 10 minutes
Defined as the time from first skin puncture to successful cannulation (minutes).
up to 10 minutes
Number of attempts to success
Time Frame: up to 10 minutes
Number of puncture attempts (1,2 or 3) needed for achieving a a successful cannulation
up to 10 minutes
Inserted cannula diameter
Time Frame: up to 10 minutes
Cannula diameter (in GA) successfully inserted
up to 10 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient age
Time Frame: 1 day (At the time of peripheral IV cannulation)
Age in years
1 day (At the time of peripheral IV cannulation)
Patient sex
Time Frame: 1 day (At the time of peripheral IV cannulation)
Female vs Male
1 day (At the time of peripheral IV cannulation)
Patient body mass index (BMI)
Time Frame: 1 day (At the time of peripheral IV cannulation)
BMI (in kg/m^2) for age percentile
1 day (At the time of peripheral IV cannulation)
Patient inotropic and vasoactive support
Time Frame: 1 day (At the time of peripheral IV cannulation)
Vasoactive-Inotropic Score (VIS score)
1 day (At the time of peripheral IV cannulation)
Admission-cannulation time
Time Frame: 1 day (At the time of peripheral IV cannulation)
Time from hospital admission to first attempt of cannulation
1 day (At the time of peripheral IV cannulation)
Reason for admission
Time Frame: 1 day (At the time of peripheral IV cannulation)
Medical vs Surgical
1 day (At the time of peripheral IV cannulation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Avichai Weissbach, MD, Rabin Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

March 1, 2020

Primary Completion (ANTICIPATED)

March 1, 2022

Study Completion (ANTICIPATED)

March 1, 2022

Study Registration Dates

First Submitted

February 9, 2020

First Submitted That Met QC Criteria

February 12, 2020

First Posted (ACTUAL)

February 13, 2020

Study Record Updates

Last Update Posted (ACTUAL)

March 13, 2020

Last Update Submitted That Met QC Criteria

March 12, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 0044-20-RMC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Venous Cannulation

Clinical Trials on US guided dynamic needle tip positioning peripheral intravenous cannulation

Subscribe